Erratum to: Scope and relevance of a pulmonary biopharmaceutical classification system AAPS/FDA/USP Workshop March 16-17th, 2015 in Baltimore, MD

• Jayne E. Hastedt,
• Per Bäckman,
• Andrew R. Clark,
• William Doub,
• Anthony Hickey,
• Guenther Hochhaus,
• Phil J. Kuehl,
• Claus-Michael Lehr,
• Peter Mauser,
• Jason McConville,
• Ralph Niven,
• Masahiro Sakagami,
• Jeffry G. Weers

Affiliations

Jayne E. Hastedt

JDP Pharma Consulting, LLC

Per Bäckman

AstraZeneca R&D

Andrew R. Clark

Aerogen Pharma

William Doub

Division of Pharmaceutical Analysis, Food and Drug Administration

Anthony Hickey

RTI International, RTP

Guenther Hochhaus

University of Florida

Phil J. Kuehl

Lovelace Respiratory Research Institute

Claus-Michael Lehr

Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS) and Saarland University

Peter Mauser

Merck Research Laboratories

Jason McConville

University of New Mexico

Ralph Niven

Novartis

Masahiro Sakagami

Virginia Commonwealth University

Jeffry G. Weers

Novartis